Page last updated: 2024-10-28

lidocaine and Arrhythmogenic Right Ventricular Cardiomyopathy

lidocaine has been researched along with Arrhythmogenic Right Ventricular Cardiomyopathy in 1 studies

Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Markiewicz-Łoskot, G1
Moric-Janiszewska, E1
Loskot, M1
Szydłowski, L1
Hollek, A1
Weglarz, L1

Other Studies

1 other study available for lidocaine and Arrhythmogenic Right Ventricular Cardiomyopathy

ArticleYear
Arrhythmogenic right ventricular dysplasia:clinical study.
    Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2007, Volume: 12, Issue:2

    Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Catheter

2007